Tyra Bioscience's total assets for Q1 2026 were $412.04M, an increase of 45.80% from the previous quarter. TYRA total liabilities were $24.46M for the fiscal quarter, a 4.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.